Bulletin 2010/15 - European Patent Office
Bulletin 2010/15 - European Patent Office
Bulletin 2010/15 - European Patent Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(A61K) II.1(1)<br />
AHMAD, Suhail, Seattle, Washington 981<strong>15</strong>,<br />
US<br />
(74) Gowshall, Jonathan Vallance, Forrester &<br />
Boehmert Pettenkoferstrasse 20-22, 80336<br />
München, DE<br />
A61K 35/14 → (51) A61K 39/00<br />
A61K 35/14 → (51) C12N 5/071<br />
(51) A61K 35/32 (11) 1 514 554 B1<br />
A61K 35/60 A61K 31/198<br />
A61K 31/164 A61K 8/68<br />
A61K 8/98 A61K 8/44<br />
A61Q 19/08<br />
(25) It (26) En<br />
(21) 04020518.9 (22) 30.08.2004<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />
TR<br />
(43) 16.03.2005<br />
(30) 03.09.2003 IT TO20030672<br />
(54) • Orale Zusammensetzung aus Naturstoffen<br />
zum Erhalt der richtigen Hautfeuchtigkeit<br />
• Oral composition based on natural substances<br />
useful in the maintenance of the<br />
correct hydration of the skin<br />
• Composition orale à base de substances<br />
naturelles permettant de maintenir une<br />
hydratation correcte de la peau<br />
(73) Medestea Internazionale S.p.A., Via Cernaia<br />
31, 10121 Torino, IT<br />
(72) Berardesca, Enzo, 00<strong>15</strong>2 Roma, IT<br />
Merizzi, Gianfranco, 10128 Torino, IT<br />
(74) Comoglio, Elena, et al, Jacobacci & Partners<br />
S.p.A. Corso Emilia 8, 10<strong>15</strong>2 Torino, IT<br />
A61K 35/60 → (51) A61K 35/32<br />
A61K 35/74 → (51) C12N 1/20<br />
(51) A61K 36/36 (11) 1 841 441 B1<br />
A23L 1/29 A61P 19/02<br />
(25) En (26) En<br />
(21) 05856245.5 (22) 22.12.2005<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />
SE SI SK TR<br />
(43) 10.10.2007<br />
(86) IB 2005/003859 22.12.2005<br />
(87) WO 2006/072823 2006/28 13.07.2006<br />
(30) 28.12.2004 US 23817<br />
(54) • EXTRAKT AUS BRACHYSTEMMA CALYCI-<br />
NUM FÜR ATHROSE<br />
• BRACHYSTEMMA CALYCINUM EXTRACT<br />
FOR OSTEOARTHRITIS<br />
• EXTRAIT DE BRACHYSTEMMA CALYCI-<br />
NUM DESTINÉ À L'ARTHROSE<br />
(73) Vita Green Health Products Co., Ltd., Workshops<br />
3-7, <strong>15</strong>/F., Oceanic Industrial Centre,<br />
No. 2 Lee Lok Street, Ap Lei Chau, Hong<br />
Kong, CN<br />
(72) Chan, Hei Ling Helen, 1 Tregunter Path, CN<br />
(74) Schaefer, Antonia, Schweiger & Partner<br />
Karlstrasse 35, 80333 München, DE<br />
(60) 10<strong>15</strong>0086.6<br />
A61K 36/53 → (51) C07D 307/33<br />
(51) A61K 38/00 (11) 0 964 693 B1<br />
A61K 38/06 C07K 5/00<br />
C07K 7/00 C07K 16/00<br />
C07K 17/00 C07K 1/00<br />
C07K 14/00 A01N 37/18<br />
C12N 1/20 C12N <strong>15</strong>/00<br />
(25) En (26) En<br />
(21) 97940829.1 (22) 05.09.1997<br />
(84) CH DE FR GB IT LI NL<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
(43) 22.12.1999<br />
(86) US 1997/0<strong>15</strong>609 05.09.1997<br />
(87) WO 1998/009639 1998/10 12.03.1998<br />
(30) 05.09.1996 US 26257 P<br />
(54) • NEUARTIGE BACTERIOCINE, TRANSPORT-<br />
UND VEKTORSYSTEM UND VERFAHREN<br />
ZUR IHRER VERWENDUNG<br />
• NOVEL BACTERIOCINS, TRANSPORT AND<br />
VECTOR SYSTEM AND METHOD OF USE<br />
THEREOF<br />
• NOUVELLES BACTERIOCINES, NOUVEAU<br />
SYSTEME DE TRANSPORT ET DE VEC-<br />
TEUR ET PROCEDE D'UTILISATION<br />
ASSOCIE<br />
(73) The Governors of the University of Alberta,<br />
Industry Liaison <strong>Office</strong>, 222 Campus Towers,<br />
8625 -112 Street, Edmonton, Alberta T6G<br />
2E1, CA<br />
(72) STILES, Michael, E., Edmonton, Alberta T6H<br />
4C3, CA<br />
VEDERAS, John, C., Edmonton, Alberta T6C<br />
3Y5, CA<br />
VAN BELKUM, Marius, J., NL-7921 HT<br />
Zuidwolde, NL<br />
WOROBO, Randy, W., Consort, Alberta T0C<br />
1BO, CA<br />
WOROBO, Rodney, J., Consort, Alberta T0C<br />
1BO, CA<br />
MCCORMICK, John, K., Nepean, Ontario K2H<br />
6C8, CA<br />
GREER, G., Gordon, Lacombe, Alberta T4L<br />
1J6, CA<br />
MCMULLEN, Lynn, M., Edmonton, Alberta<br />
T6E 1J4, CA<br />
LEISNER, Jorgen, J., Kembangan Selangor<br />
D.E., MY<br />
POON, Alison, Edmonton, Alberta T6J OP8,<br />
CA<br />
FRANZ, Charles, M., A., P., D-76139 Karlsruhe,<br />
DE<br />
(74) Gates, Marie Christina Esther, et al, Tomkins<br />
& Co. 5 Dartmouth Road, Dublin 6, IE<br />
A61K 38/00 → (51) C07K 14/00<br />
(51) A61K 38/03 (11) 1 318 828 B1<br />
A61K 38/08 A61K 38/10<br />
A61K 38/17 C07K 14/775<br />
(25) En (26) En<br />
(21) 01966198.2 (22) 23.08.2001<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE TR<br />
(43) 18.06.2003<br />
(86) US 2001/026497 23.08.2001<br />
(87) WO 2002/0<strong>15</strong>923 2002/09 28.02.2002<br />
(30) 24.08.2000 US 645454<br />
(54) • PERORAL-VERABREICHTE PEPTIDE ZUR<br />
BESSERUNG VON ATHEROSKLEROSE<br />
• ORALLY ADMINISTERED PEPTIDES TO<br />
AMELIORATE ATHEROSCLEROSIS<br />
• PEPTIDES ADMINISTRES PER OS POUR<br />
AMELIORER LES SYMPTOMES DE<br />
L'ATHEROSCLEROSE<br />
(73) The Regents of The University of California,<br />
5th Floor, 1111 Franklin Street, Oakland, CA<br />
94607-5200, US<br />
The UAB Research Foundation, 701 South<br />
20th Street Suite 1120G, Birmingham, AL<br />
35291-0111, US<br />
(72) FOGELMAN, Alan, M., Beverly Hills, CA<br />
90212-4107, US<br />
ANANTHARAMAIAH, Gattadahalli, M., Birmingham,<br />
AL 35226, US<br />
NAVAB, Mohamad, Los Angeles, CA 90066-<br />
1735, US<br />
(74) Ward, David Ian, Marks & Clerk LLP Alpha<br />
Tower Suffolk Street, Queensway Birmingham<br />
B1 1TT, GB<br />
(60) 07007775.5 / 1 864 675<br />
532<br />
<strong>Patent</strong>e<br />
<strong>Patent</strong>s<br />
Brevets (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />
A61K 38/06 → (51) A61K 38/00<br />
A61K 38/08 → (51) A61K 38/03<br />
A61K 38/10 → (51) A61K 38/03<br />
A61K 38/10 → (51) C12N <strong>15</strong>/12<br />
A61K 38/17 → (51) A61K 38/03<br />
A61K 38/17 → (51) C07K 14/705<br />
A61K 38/18 → (51) A61K 39/395<br />
(51) A61K 38/19 (11) 1 347 773 B1<br />
A61P 35/00 A61K 31/555<br />
(25) En (26) En<br />
(21) 02707393.1 (22) 03.01.2002<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE TR<br />
(43) 01.10.2003<br />
(86) US 2002/000036 03.01.2002<br />
(87) WO 2002/053142 2002/28 11.07.2002<br />
(30) 05.01.2001 US 260120 P<br />
(54) • ZUSAMMENSETZUNGEN UND VERFAH-<br />
REN ZUR ERHÖHUNG DER ZYTOKIN-<br />
AKTIVITÄT UND ZUR BEHANDLUNG DER<br />
HYPOTENSION ASSOZIIERT MIT DER<br />
VERABREICHUNG VON ZYTOKINEN<br />
• COMPOSITIONS AND METHODS FOR<br />
ENHANCING CYTOKINE ACTIVITY AND<br />
TREATING HYPOTENSION ASSOCIATED<br />
WITH THE ADMINISTRATION OF CYTO-<br />
KINES<br />
• COMPOSITIONS ET METHODES PERMET-<br />
TANT D'AMELIORER L'ACTIVITE D'UNE<br />
CYTOKINE ET DE TRAITER L'HYPOTEN-<br />
SION ASSOCIEE A L'ADMINISTRATION DE<br />
CYTOKINES<br />
(73) MetaPhore Pharmaceuticals, Inc., 1910<br />
Innerbelt Business Center Drive, St. Louis,<br />
MO 63114, US<br />
(72) SALVEMINI, Daniela, Chesterfield, MO<br />
63017, US<br />
(74) Smaggasgale, Gillian Helen, W.P. Thompson<br />
& Co 55 Drury Lane, London WC2B 5SQ, GB<br />
(51) A61K 38/20 (11) 1 491 208 B1<br />
A61K 38/57 A61K 38/21<br />
A61K 47/18<br />
(25) En (26) En<br />
(21) 04021066.8 (22) 03.10.2000<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE<br />
(43) 29.12.2004<br />
(30) 04.10.1999 US <strong>15</strong>7696 P<br />
(54) • Stabilisierte flüssige pharmazeutische<br />
Zusammensetzung enthaltend TFPI<br />
• Stabilized liquid pharmaceutical compositions<br />
containing TFPI<br />
• Compositions pharmaceutiques liquides<br />
stabilisées contenant le TFPI<br />
(73) Novartis Vaccines and Diagnostics, Inc.,<br />
4560 Horton Street, Emeryville, CA 94608,<br />
US<br />
(72) Chen, Bao-Lu, Emeryville, CA 94622-8097,<br />
US<br />
Hora, Maninder, Emeryville, CA 94622-8097,<br />
US<br />
(74) Marshall, Cameron John, Carpmaels &<br />
Ransford 43-45 Bloomsbury Square, London<br />
WC1A 2RA, GB<br />
(62) 00968584.3 / 1 220 682<br />
A61K 38/21 → (51) A61K 38/20<br />
A61K 38/22 → (51) C12N <strong>15</strong>/00